v3.22.2.2
Condensed Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Operating expenses:        
Research and development $ 1,473 $ 435 $ 2,568 $ 1,340
Selling, general and administrative 3,002 4,961 6,474 9,318
Total operating expenses 4,475 5,396 9,042 10,658
Loss from operations (4,475) (5,396) (9,042) (10,658)
Other income (expense):        
Other income 6
Interest expense (2) (2) (5) (533)
Loss on exchange of notes payable for common stock and warrants (6)
Gain (loss) on extinguishment of debt (13,805)
Change in fair value of warrant liability (1,024)
Change in fair value of derivative liability (51)
Total other income (expense) (2) (2) (5) (15,413)
Net loss $ (4,477) $ (5,398) $ (9,047) $ (26,071)
Net loss per share, basic and diluted: (in Dollars per share) $ (0.27) $ (0.38) $ (0.56) $ (1.97)
Weighted average shares outstanding, basic and diluted: (in Shares) 16,419,699 14,315,142 16,139,564 13,241,786

Source